Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
SC5D - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RABL2A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
ARFGEF3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
APLP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HIBCH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C1QTNF3-AMACR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TSPAN12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00900 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARCN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GPAM - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ERMP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STX7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TAF9B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ENTPD1-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SHROOM3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC30A9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RALGAPA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on